Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Behr (Munich, Germany), M. Kolb (Hamilton, Ontario, Canada), H. Olschewski (Graz, Austria), J. Song (Seoul , Republic of Korea), F. Luppi (ASST Monza, Italy), B. Schinzel (Ingelheim am Rhein, Germany), S. Stowasser (Ingelheim am Rhein, Germany), M. Quaresma (Ingelheim am Rhein, Germany), F. Martinez (New York , United States of America). Does brain natriuretic peptide (BNP) at baseline influence the effects of nintedanib plus sildenafil in patients with IPF?. 2251

Member's Comments

No comment yet.

Related content which might interest you: Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 The utility of brain natriuretic peptide in patients with stable chronic lung diseases Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020 Year: 2020 The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006 Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 New evidence of the effect of B-type natriuretic peptide (BNP) on human bronchi Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases Year: 2007 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Effects of brain natriuretic peptide (BNP) on contractile response in human isolated bronchi Source: Annual Congress 2009 - Translational models of lung disease Year: 2009 Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020